IP Library Granted Patent US 8,129,168
Granted Patent B2
US 8,129,168 · App. 12/687,677 · Granted Mar 6, 2012

Recombinant colwellia psychrerythraea alkaline phosphatase and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,129,168
App. No.
12/687,677
Granted
Mar 6, 2012
Kind
B2
Abstract

A heat labile alkaline phosphatase enzyme and methods of using the same and kits including the same are disclosed. Specifically, a nucleotide sequence of, peptide sequence of, methods of using, and kits comprising, a heat labile alkaline phosphatase isolated from Colwellia psychrerythraea are provided. Methods of over-expression and purification of the recombinant alkaline phosphatase and mutants thereof are also disclosed. Methods of over-expressing and purifying commercially useful quantities of active recombinant heat labile alkaline phosphatase fusion enzymes from C. psychrerythraea , wherein the fusion enzymes comprise one or more heterologous leader sequences are disclosed. The disclosed C. psychrerythraea heat labile alkaline phosphatase has properties similar to shrimp alkaline phosphatase and can be substituted for shrimp alkaline phosphatase in assays involving the same.

Claims (31)

1. An isolated nucleic acid comprising:

a) the sequence of SEQ ID NO:3; or

b) a sequence which is at least 95% identical to SEQ ID NO:3;

wherein the sequence further comprises a nucleic acid sequence encoding a hydrophilic repeating polypeptide sequence, wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14, and wherein the isolated nucleic acid encodes a polypeptide with dephosphorylation activity.

2. The sequence according to claim 1 , consisting essentially of the sequence of SEQ ID NO:3, wherein the sequence further comprises a nucleic acid sequence encoding a hydrophilic repeating polypeptide sequence, wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14.

3. The sequence according to claim 1 , consisting of SEQ ID NO:3, wherein the sequence further comprises a nucleic acid sequence encoding a hydrophilic repeating polypeptide sequence, wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14.

4. An isolated vector comprising:

a) the sequence of SEQ ID NO:3; or

b) a sequence which is at least 95% identical to SEQ ID NO:3;

wherein the sequence further comprises a nucleic acid sequence encoding a hydrophilic repeating polypeptide sequence, wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14, and wherein the sequence encodes a polypeptide with dephosphorylation activity.

5. An isolated bacterial cell comprising a vector, wherein said vector comprises:

a) the sequence of SEQ ID NO:3; or

b) a sequence which is at least 95% identical to SEQ ID NO:3;

wherein the sequence further comprises a nucleic acid sequence encoding a hydrophilic repeating polypeptide sequence, wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14, and wherein the sequence encodes a polypeptide with dephosphorylation activity.

6. The isolated nucleic acid according to claim 1 , wherein the nucleic acid sequence encoding the hydrophilic repeating polypeptide sequence is upstream of the sequence of SEQ ID NO:3 or the sequence which is at least 95% identical to SEQ ID NO:3.

7. The isolated nucleic acid according to claim 1 , wherein the nucleic acid sequence encoding the hydrophilic repeating polypeptide sequence is downstream of the sequence of SEQ ID NO:3 or the sequence which is at least 95% identical to SEQ ID NO:3.

8. A nucleic acid comprising the sequence of SEQ ID NO:3, wherein the sequence further comprises a nucleic acid sequence encoding a hydrophilic repeating polypeptide sequence, and wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS: 4 and 8-14.

9. A vector comprising the sequence of SEQ ID NO:3, wherein the sequence further comprises a nucleic acid sequence encoding a hydrophilic repeating polypeptide sequence, and wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14.

10. A bacterial cell comprising a vector, wherein the vector comprises the sequence of SEQ ID NO:3, wherein the sequence further comprises a nucleic acid sequence encoding a hydrophilic repeating polypeptide sequence, and wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14.

11. A nucleic acid comprising:

a) the sequence which is fully complementary to SED ID NO:3; or

b) the sequence which hybridizes to SEQ ID NO:3 under stringent conditions, wherein the stringent conditions comprise a salt concentration of less than 1 M and a temperature of at least 25° C.;

wherein the sequence further comprises a first nucleic acid sequence, wherein the first nucleic acid sequence is fully complementary to a second nucleic acid sequence, wherein the second nucleic acid sequence encodes a hydrophilic repeating polypeptide sequence, and wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14.

12. A vector comprising:

a) the sequence which is fully complementary to SED ID NO:3; or

b) the sequence which hybridizes to SEQ ID NO:3 under stringent conditions, wherein the stringent conditions comprise a salt concentration of less than 1 M and a temperature of at least 25° C.;

wherein the sequence further comprises a first nucleic acid sequence, wherein the first nucleic acid sequence is fully complementary to a second nucleic acid sequence, wherein the second nucleic acid sequence encodes a hydrophilic repeating polypeptide sequence, and wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14.

13. A bacterial cell comprising a vector, wherein said vector comprises:

a) the sequence which is fully complementary to SED ID NO:3; or

b) the sequence which hybridizes to SEQ ID NO:3 under stringent conditions, wherein the stringent conditions comprise a salt concentration of less than 1 M and a temperature of at least 25° C.;

wherein the sequence further comprises a first nucleic acid sequence, wherein the first nucleic acid sequence is fully complementary to a second nucleic acid sequence, wherein the second nucleic acid sequence encodes a hydrophilic repeating polypeptide sequence, and wherein the hydrophilic repeating polypeptide sequence is selected from the group consisting of: HQ, HQHQ, SEQ ID NOS:4 and 8-14.

Assignments (5)
NOTICE OF RELEASE Recorded Apr 5, 2016
From: BANK OF AMERICA, N.A.
To: AFFYMETRIX, INC.
Reel/Frame 038361/0891 →
RELEASE OF SECURITY INTEREST Recorded Nov 13, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: AFFYMETRIX, INC.
Reel/Frame 037109/0132 →
SECURITY INTEREST Recorded Oct 28, 2015
From: AFFYMETRIX, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036988/0166 →
SECURITY AGREEMENT Recorded Jun 27, 2012
From: AFFYMETRIX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 028465/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2010
From: MULLER-GREVEN, JEANNINE C.; POST, MARC A.; KUBU, CHRISTOPHER J.
To: AFFYMETRIX, INC.
Reel/Frame 024118/0260 →